Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Patient’s own glioblastoma cells used to treat tumour

The glioblastoma cells of a patient are used to treat tumour. In picture, MRI scan of a glioblastoma of a brain tumour

Source: Sherbrooke Connectivity Imaging Lab / Science Photo Library

Glioblastoma cells were extracted during brain surgery and used to treat the patient’s tumour

Glioblastoma is an aggressive form of brain tumour with a poor prognosis. Hopes for a vaccine to tackle the disease are bolstered by positive results from a phase I trial reported in Cancer Immunology and Immunotherapy (online, 14 November 2014)[1].

The vaccine, developed by Larry Harshyne and team at Thomas Jefferson University, Philadelphia, Pennsylvania, consists of the patient’s own glioblastoma cells extracted during brain surgery to remove the tumour. The tumour cells are incubated with an antisense oligodeoxynucleotide directed against the insulin-like growth factor type 1 receptor and then packaged inside a diffusion chamber that is inserted into the patient’s abdomen.

Out of 12 patients, the vaccine elicited a positive clinical response in eight patients and an immune response in six patients. Further clinical trials are planned for January 2015. 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20067192

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.